Zevra Therapeutics Inc 2025年季度报告

FORM10-Q OR Zevra Therapeutics, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware(State or Other Jurisdiction ofIncorporation or Organization)(I.R.S. EmployerIdentification No.) 34747(Zip Code) (321)939-3416(Registrant’s Telephone Number, Including Area Code) (Former Name, Former Address, and Former Fiscal Year if Changed Since Last Report) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant: (1)has filed all reports required to be filed by Section 13 or 15(d) of the Securities ExchangeAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant toRule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reportingcompany, or an emerging growth company. See the definitions of "large accelerated filer,""accelerated filer," "smaller reporting company," Accelerated filerSmaller reportingcompanyEmerging growth If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complyingwith any new or revised financial accounting standards provided pursuant toSection 13(a) of the Exchange Act.☐ SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q, including the section entitled“Management’s Discussion and Analysis of Financial Condition andResults of Operations,”contains forward-looking statements regarding future events and our future results that are subject to the safe harborscreated under the Securities Act of 1933, as amended, or the Securities Act, and the Securities Exchange Act of 1934, as amended, or theExchange Act. Forward-looking statements relate to future events or our future financial performance. We generally identify forward-lookingstatements by terminology such as“may,”“will,”“would,”“should,”“expects,”“plans,”“anticipates,”“could,”“intends,”“target,”“projects,”“contemplates,”“believes,”“estimates,”“predicts,”“assume,”“intend,”“potential,”“continue”or other similar words or thenegative of these terms.We have based these forward-looking statements largely on our current expectations about future events and financialtrends that we believe may affect our business, financial condition and results of operations. The outcome of the events described in theseforward-looking statements is subject to risks, uncertainties and other factors described in“Risk Factors”of our Annual Report on Form 10-K ●our ability to commercialize and the timing of commercializing our products and product candidates, if approved; ●the potential therapeutic benefits and effectiveness of our products and product candidates; ●the progress of, timing of and expected amount of expenses associated with our commercialization, research, and development activities; ●the size and characteristics of the markets that may be addressed by our products and product candidates; ●the expected timing of our clinical trialsfor our product candidates and the availability of data and results of those trials; ●the progress of, outcome ofand timing of any regulatory approval for any of our product candidates and the expected amount or timingof any payment related thereto under any of our collaboration agreements; ●our expectations regarding federal, state and foreign legal and regulatory requirements; ●our intention to seek to establish, and the potential benefits to us from, anystrategic collaborations or partnerships for the developmentor sale of our products and product candidates, if approved; ●our expectations as to future financial performance, expense levels and liquidity sources; ●the sufficiency of our cash resources to fund our operating expenses and capital investment requirements for any period; ●our ability to raise additional funds on commercially reasonable terms, or at all, in order to support our continued operations; ●senior leadership and board member transitions and refreshments; and ●other factors discussed elsewhere in this report. The forward-looking statements made in this report relate only to events as of the date on which the statements are made. We have included ormade reference to important factors in the cautionary statements included in this report, particularly in the section entitled “Risk Factors”where we make reference toPart I, Item 1A. “Risk Factors” of our Annual Report on Form 10-K, that we believe could cause actual results orevents to differ materially from the forward-looking statements that we make. Our forward-looking statements do not reflect the potential NOTE REGARDING COMPAN